| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Unità di Genetica Medica, Policlinico Universitario S. Orsola-Malpighi; 2 Dipartimento di Biologia Evoluzionistica Sperimentale, 3 Dipartimento di Biochimica, 4 Dipartimento di Scienze Neurologiche, and 5 Dipartimento di Anatomia Patologica, Università di Bologna, Bologna, Italy; and 6 Istituto Scientifico "E. Medea," Conegliano Veneto, Italy
Requests for reprints: Elena Bonora, Unità di Genetica Medica, Dip. Medicina Interna, Policlinico Universitario S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy. Phone: 39-051-429-2007; Fax: 39-051-636-4004; E-mail: elena.bonora{at}eurogene.org.
Oncocytic tumors are characterized by cells with an aberrant accumulation of mitochondria. To assess mitochondrial function in neoplastic oncocytic cells, we studied the thyroid oncocytic cell line XTC.UC1 and compared it with other thyroid non-oncocytic cell lines. Only XTC.UC1 cells were unable to survive in galactose, a condition forcing cells to rely solely on mitochondria for energy production. The rate of respiration and mitochondrial ATP synthesis driven by complex I substrates was severely reduced in XTC.UC1 cells. Furthermore, the enzymatic activity of complexes I and III was dramatically decreased in these cells compared with controls, in conjunction with a strongly enhanced production of reactive oxygen species. Osteosarcoma-derived transmitochondrial cell hybrids (cybrids) carrying XTC.UC1 mitochondrial DNA (mtDNA) were generated to discriminate whether the energetic failure depended on mitochondrial or nuclear DNA mutations. In galactose medium, XTC.UC1 cybrid clones showed reduced viability and ATP content, similarly to the parental XTC.UC1, clearly pointing to the existence of mtDNA alterations. Sequencing of XTC.UC1 mtDNA identified a frameshift mutation in ND1 and a nonconservative substitution in cytochrome b, two mutations with a clear pathogenic potential. In conclusion, this is the first demonstration that mitochondrial dysfunction of XTC.UC1 is due to a combined complex I/III defect associated with mtDNA mutations, as proven by the transfer of the defective energetic phenotype with the mitochondrial genome into the cybrids. (Cancer Res 2006; 66(12): 6087-96)
This article has been cited by other articles:
![]() |
J. A. Mayr, D. Meierhofer, F. Zimmermann, R. Feichtinger, C. Kogler, M. Ratschek, N. Schmeller, W. Sperl, and B. Kofler Loss of Complex I due to Mitochondrial DNA Mutations in Renal Oncocytoma Clin. Cancer Res., April 15, 2008; 14(8): 2270 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gasparre, E. Hervouet, E. de Laplanche, J. Demont, L. F. Pennisi, M. Colombel, F. Mege-Lechevallier, J.-Y. Scoazec, E. Bonora, R. Smeets, et al. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma Hum. Mol. Genet., April 1, 2008; 17(7): 986 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zanna, A. Ghelli, A. M. Porcelli, M. Karbowski, R. J. Youle, S. Schimpf, B. Wissinger, M. Pinti, A. Cossarizza, S. Vidoni, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion Brain, February 1, 2008; 131(2): 352 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Kim, W. S. Park, S. H. Kang, M. Warda, N. Kim, J.-H. Ko, A. E.-b. Prince, and J. Han Mitochondrial alterations in human gastric carcinoma cell line Am J Physiol Cell Physiol, August 1, 2007; 293(2): C761 - C771. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gasparre, A. M. Porcelli, E. Bonora, L. F. Pennisi, M. Toller, L. Iommarini, A. Ghelli, M. Moretti, C. M. Betts, G. N. Martinelli, et al. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors PNAS, May 22, 2007; 104(21): 9001 - 9006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, J. N. Barrett, and C. T. Moraes PGC-1{alpha}/{beta} upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations Hum. Mol. Genet., April 15, 2007; 16(8): 993 - 1005. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |